TY - JOUR T1 - Assessment of the Impacts of Pharmaceutical and Non-pharmaceutical Intervention on COVID-19 in South Africa Using Mathematical Model JF - medRxiv DO - 10.1101/2020.11.13.20231159 SP - 2020.11.13.20231159 AU - Rabiu Musa AU - Absalom E. Ezugwu AU - Godwin C. E. Mbah Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/16/2020.11.13.20231159.abstract N2 - The novel coronal virus has spread across more than 213 countries within the space of six months causing devastating public health hazard and monumental economic loss. In the absence of clinically approved pharmaceutical intervention, attentions are shifted to non-pharmaceutical controls to mitigate the burden of the novel pandemic. In this regard, a ten mutually exclusive compartmental mathematical model is developed to investigate possible effects of both pharmaceutical and non-pharmaceutical controls incorporating both private and government’s quarantine and treatments. Several reproduction numbers were calculated and used to determine the impact of both control measures as well as projected benefits of social distancing, treatments and vaccination. We investigate and compare the possible impact of social distancing incorporating different levels of vaccination, with vaccination programme incorporating different levels of treatment. Using the officially published South African COVID-19 data, the numerical simulation shows that the community reproduction threshold will be 30 when there is no social distancing but will drastically reduced to 5 (about 83% reduction) when social distancing is enforced. Furthermore, when there is vaccination with perfect efficacy, the community reproduction threshold will be 4 which increases to 12 (about 67% increment) with-out vaccination. We also established that the implementation of both interventions is enough to curtail the spread of COVID-19 pandemic in South Africa which is in confirmation with the recommendation of the world health organization.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNo external funding was received for this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is available within the body of the manuscript ER -